Agenda
9:00 – 10:00 am | Onsite Check-in and Networking |
---|---|
10:00 – 10:10 am | Welcome & Opening Remarks |
Summit Co-Chair: William J. Link, PhD, Managing Director – Versant Ventures |
|
10:10 – 11:15 am | Private Ophthalmic Companies Showcase |
Private Ophthalmic Companies Showcase (6 minutes each)
Co-Moderators: |
|
11:15 – 11:30 am | Networking Break |
Hosted By:![]() |
|
11:30 am – 12:30 pm | Review of the Ophthalmology Innovation Cycle |
Innovation cycle overview and financing environment update (10 minutes) William J. Link, PhD, Managing Director – Versant Ventures Sometimes things don’t go as planned. Where in the innovation cycle did it go wrong? (5 minutes each)
Panel discussion (30 minutes) Co-Moderators: |
|
12:30 – 1:30 pm | Networking Lunch & Ophthalmology Innovator Award Presentation |
Award Recipient: Mark Forchette, CEO – OptiMedica Mark Forchette serves as president and CEO of OptiMedica. Forchette has more than two decades of experience in ophthalmic sales, marketing and business unit management. Immediately prior to OptiMedica, he serves as vice president of global marketing and sales for the vitreoretinal business unit of Alcon. In this postion, he led the vitreoretinal unit through a period of substantial portfolio enhancement, infrastructure development and a significant increase in market share. Prior to Alcon, Mr. Forchette was vice president of sales and marketing at Grieshaber & Co. Inc., where he let the privately-held Swiss company’s domestic operations through major infrastructure and revenue expansion Presented By: Hosted By: |
|
1:30 – 2:15 pm | The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation |
Panel Discussion Panelists: Singapore – Donald Tan, MD, Director – Singapore National Eye Centre Switzerland – Michael Mrochen, PhD, Founder & CEO – IROC Science to Innovation Argentina – Roberto Zaldivar, MD, President – Instituto Zaldivar S.A. Italy – Matteo Piovella, MD, Director – Centro di Microchirurgia Ambulatoriale Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation – FDA Aron Shapiro, Vice President – Ora Moderator: |
|
2:15 – 3:00 pm | Dry Eye – Challenges & Opportunities |
Market Overview: (5 minutes) Edward J. Holland, MD, Director of Cornea Services & Professor of Ophthalmology – Cincinnati Eye Institute Company Presentations: (5 minutes each = 25 mins)
Panel Discussion: The role dry eye technologies and therapies do/will play in the ophthalmic practice (15 minutes) Co-Moderators: |
|
3:00 – 3:30 pm | Networking Break |
Hosted By:![]() |
|
3:30 – 4:15 pm | Corneal Cross Linking – An Emerging Field |
Market Overview: (5 minutes) Stephen Slade, MD, Surgeon – Slade & Baker Vision Center Company Presentations: (5 minutes each = 15 minutes)
Panel Discussion: Challenges & Opportunities for Cross Linking Technoogies (25 minutes) Co-Moderators: |
|
4:15 – 5:00 pm | Industry Perspective on the Topics of the Day |
Panelists: Abbott Medical Optics – Jane E. Rady, Division VP, Business Development Bausch + Lomb – Calvin W. Roberts, MD, Sr. Vice President & Chief Medical Officer Shire – Quinton Oswald, President & CEO – Neurotech Alcon – Laurent Attias, Head, Global Commercial Strategy Moderator: |
|
5:00 – 5:10 pm | Closing Remarks |
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures | |
5:10 – 6:30 pm | Networking Reception |
Hosted By:![]() |